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Progressive resistance plus balance training for older Australians receiving in-home care services: 1 
Cost-effectiveness analyses alongside the Muscling Up Against Disability stepped-wedge randomized 2 
control trial.  3 
2 
 
ABSTRACT 1 
In this paper we assess the cost-effectiveness of center-based exercise training for older Australians. 2 
Participants were recipients of in-home care services and completed 24-weeks of progressive 3 
resistance plus balance training. Transport was offered to all participants. A stepped-wedge 4 
randomized control trial produced pre, post and follow up outcome and cost data which were used 5 
to calculate incremental cost-effectiveness ratios per quality-adjusted life year (QALY) gained. 6 
Analyses were conducted from the health provider perspective and from a government perspective. 7 
From a health service provider perspective the direct cost of program provision was $303 per 8 
person, with transport adding an additional $1,920 per person.  The incremental cost-utility ratio of 9 
the program relative to usual care was $70,540 per QALY over six months, reducing to $37,816 per 10 
QALY over 12 months. The findings suggest that Muscling Up Against Disability offers good value for 11 
money within commonly accepted threshold values. 12 
 13 
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INTRODUCTION 1 
Globally the population is ageing, and with increasing age comes decline in functional capacity and a 2 
reduced ability to remain living independently. In Australia, projections to the year 2050 suggest that 3 
demand for home assistance and residential aged care placement will more than triple (Productivity 4 
Commission, 2012). The Australian government Commonwealth Home Support Programme (CHSP) is 5 
an initiative that enables adults experiencing the early stages of functional decline to remain in their 6 
homes, through access to supported services such as domestic assistance and personal care. While 7 
the intention of this service is to facilitate continued independence, in practice, little exercise 8 
therapy is provided in this program to promote rehabilitation of physical function (Commonwealth 9 
of Australia, 2017). 10 
 11 
For adults receiving in-home care services through the CHSP, progressive resistance plus balance 12 
training has the potential to improve their physical function, physical capacity and promote 13 
independence (Henwood, Riek, & Taaffe, 2008; Liu & Latham, 2011). However a majority of research 14 
continues to focus on low intensity activities that do not employ the technique of progressive 15 
overload (Muramatsu, Yin, Berbaum, et al., 2017; Muramatsu, Yin, & Lin, 2017; Sherrington, 16 
Tiedemann, Fairhall, Close, & Lord, 2011). Further, little attention has been given to overcoming 17 
barriers to participation in exercise programs, such as access to transport, or to creating 18 
environments conducive to exercise for adults with aged care needs. Cost-effectiveness data for any 19 
such exercise programs are scant, making it difficult for organisations to evaluate, select and plan for 20 
implementation of a specific intervention. 21 
 22 
In this paper we assess the cost-effectiveness of Muscling Up Against Disability, a 24-week 23 
progressive resistance plus balance training program delivered twice weekly, as compared to usual 24 
care, in older Australians receiving in-home care services through the CHSP. Cost explorations 25 
include the provision of transport to and from the study site in order to overcome this particular 26 
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barrier to participation. Cost savings attributable to decreased health care utilization are also 1 
explored in the analyses. 2 
 3 
METHODS 4 
Muscling Up Against Disability was a stepped-wedge randomized control trial to assess the effect of 5 
a progressive resistance plus balance training exercise intervention on the physical and mental 6 
health of 245 older Australians receiving CHSP services. The study was conducted from August 2015 7 
to August 2017 in Brisbane, Australia. Ethics approval for the study was obtained from the University 8 
of Queensland Human Research Ethics Committee (approval number #2015000879) and the study 9 
registered with the Australian New Zealand Clinical Trials Registry (ACTRN12615001153505). Details 10 
of the study protocol have been published (Keogh et al., 2017). 11 
 12 
Intervention arm 13 
The intervention was 24 weeks of twice-weekly, evidence-based, progressive resistance plus balance 14 
training delivered at a community center in Brisbane, Queensland, Australia. An exercise area within 15 
the center was reserved specifically for this study. The program combined resistance exercises with 16 
specific balance training. Participants were supervised by accredited exercise physiologists 17 
experienced in exercise delivery for older adults with aged care needs. 18 
Sessions included a light five-minute warm-up, generally based around walking, followed by 45 19 
minutes of machine-based resistance training and targeted balance exercises. Resistance exercises 20 
were; leg press, leg extension & flexion, leg abduction & adduction, chest press, seated row, 21 
abdominal curl. Balance exercise were; box step, tightrope walk, single leg stand and calf raises. 22 
Exercise sessions concluded with a five minute cool down incorporating stretching. Resistance 23 
exercises were performed on air-pressure driven, computer-integrated HUR equipment (HUR Labs 24 
Oy, Tampere, Finland).  25 
 26 
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Control arm 1 
The intervention effects were compared with usual care plus healthy living seminars. Usual care was 2 
chosen as it is the comparator of choice in pragmatic trials. Participants in the usual care group were 3 
instructed to continue with their usual activities and to not to take up an exercise regime during the 4 
control period. Participants were provided with monthly healthy living sessions of approximately one 5 
hour duration consisting of ~30-minute educational seminars and a light morning tea. The rationale 6 
for including the seminars in the usual care was as an incentive for continued participation in the 7 
study by the control group participants. 8 
 9 
Transport 10 
Transport was provided to all participants who requested it to aid in overcoming a primary barrier to 11 
exercise attendance for older adults (Franco et al., 2015; Moschny, Platen, Klaaßen-Mielke, 12 
Trampisch, & Hinrichs, 2011).  Transport was available between home and the study site for 13 
assessments, exercise sessions and the healthy living seminars. Transport included door-to-door 14 
participant mobility and transfer assistance from drivers. Transport times were entered as recurrent 15 
bookings in a fleet management system ensuring that a vehicle would arrive unless the participant 16 
rang to cancel transport on any given day (e.g. due to illness). 17 
 18 
Participants 19 
Participants were community-dwelling older adults receiving CHSP services. Participants were 20 
recruited from the membership database of a Brisbane community and senior citizens’ center that 21 
offered, among a suite of other services, domestic assistance, personal care, day respite and 22 
transport for older adults with government supported aged care packages. A letter was sent to a 23 
random selection of the organization’s membership who were receiving in-home aged care services.  24 
From the membership mail out, 388 individuals returned an expression of interest in the study and 25 
349 were found eligible by telephone interview. These individuals were forwarded a study pack 26 
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containing the participant information sheet, the consent form, health history questionnaire and 1 
balance questionnaire; they were also scheduled to attend the exercise clinic for baseline 2 
assessment. Of these, 104 withdrew from the study prior to baseline assessment. The participant’s 3 
doctor was forwarded a study brief, identifying the individual’s intention to participate in the study 4 
and requesting they contact the research manager if they had any concerns. Assessments were 5 
conducted in the same exercise clinic in which the training occurred. Following the baseline 6 
assessment, participants were randomized to immediate exercise or wait-list control at a ratio of 1:2 7 
using block randomization through a sealed envelope selection method. The project employed a 8 
modified stepped-wedge randomization to ensure all participants were given the opportunity to 9 
benefit from the exercise intervention (see Appendix 1). Eligibility criteria were: (i) over 65 years of 10 
age, (ii) community-dwelling, (iii) with an Australian government aged care package, (iv) mobile with 11 
or without an aid, (v) able to follow instructions and commit to the study period, and (vi) with no 12 
recent history of resistance exercise. Exclusion criteria were: (i) requiring more than one person to 13 
assist with transfers, standing and/or mobilising, (ii) medications and/or diseases with 14 
contraindications for exercise, (iii) terminal illness or receiving palliative care, (iv) an imminent move 15 
to residential care, (v) difficult behaviours and (vi) inability to obtain a doctor’s consent to 16 
participate. Informed written consent was obtained from participants prior to entering the study. 17 
 18 
Costs 19 
All costs are reported in 2016 Australian dollars. The cost of delivering the intervention and usual 20 
care were calculated from a health service provider perspective. Intervention direct costs were 21 
calculated using the actual cost measured during the trial and included the cost of leasing equipment 22 
and personnel time to deliver the intervention. Overhead costs were estimated at 23% of personnel 23 
costs, accounting for facility costs and administration personnel. Indirect costs were calculated for 24 
transport for those participants who elected to receive it in order to attend the study site. Research-25 
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related costs were excluded from analyses as they were not related to the delivery of the 1 
intervention and were therefore not relevant to this economic evaluation. 2 
Estimates of health care utilization are derived from an Australian government health sector 3 
perspective. Participant use of health care services between baseline and 48 weeks (intervention 4 
group) and 72 weeks (control group) was self-reported and collected using daily diaries. Participants 5 
recorded (yes or no) on a daily basis whether they visited their general practitioner, visited another 6 
medical specialist, went to the emergency department or had an overnight hospital stay. In support 7 
of the use of daily diaries, Short et al. (2009) concluded that self-reported healthcare utilization 8 
could be relied upon as a proxy for financial outcome measures when the recall required is within 9 
one month. Health care costs for emergency department and hospitalizations were derived from the 10 
Independent Hospital Pricing Authority report 2016 (Independent Hospital Pricing Authority, 2016) 11 
and general practitioner and specialist fees were derived from the Australian Medical Association list 12 
of service fees 2016 (Australian Medical Association, 2016). 13 
 14 
Outcome measures 15 
The primary outcome measure for the cost-utility analysis was the quality-adjusted life year (QALY). 16 
The QALY is a health state preference measure that combines length of life and quality of life 17 
measured using a utility weight. Utility weights were calculated from the EuroQol generic health 18 
index (EQ-5D-3L) questionnaire using the published Australia-specific algorithm (Viney et al., 2011). 19 
The EQ-5D-3L has been shown to be sensitive to change in health status in older populations (Lung 20 
et al., 2017; van Leeuwen et al., 2015). The EQ-5D-3L was administered verbally during individual 21 
assessments to the control group at baseline; and to both groups pre-exercise, post-exercise and at 22 
24 weeks follow-up (see Appendix 1).  23 
Australian tariff values (Viney et al.) were applied to EQ-5D-3L responses at each time point to 24 
provide EQ-5D-3L utility values with mean values subsequently compared across the groups and 25 
periods. Overall effectiveness of the intervention was assessed by calculating QALYs gained during 26 
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the intervention period using the area under the curve method and adjusting for baseline utility 1 
scores (Manca, Hawkins, & Sculpher, 2005).  2 
The primary outcome for the cost-effectiveness analysis was the change in score on the short 3 
physical performance battery (SPPB). The SPPB was chosen as the outcome measure for the cost-4 
effectiveness analysis as it is a well-validated measure for assessing lower extremity physical 5 
function in older adults(Curb et al., 2006; Freire, Guerra, Alvarado, Guralnik, & Zunzunegui, 2012). 6 
The SPPB measures balance, gait and lower body muscular strength. The summary score for the 7 
SPPB, ranging from zero (worst performance) to 12 (best performance), indicates physical function 8 
(Guralnik et al., 1994). 9 
 10 
Cost-effectiveness analysis 11 
Cost-effectiveness during the intervention period was assessed by quantifying the incremental cost-12 
effectiveness ratio (ICER; costs per extra QALY gained or extra point on the SPPB). Three scenarios 13 
were considered for the cost-utility and cost-effectiveness analyses. Scenario one and two were 14 
from the perspective of the health service provider. Scenario one was a six month timeframe 15 
consistent with the active intervention period and Scenario two was 12-months including follow-up. 16 
For the 12 month analysis, follow up data was available for the intervention group however 17 
outcomes for the control group were only measured to six months due to the stepped-wedge 18 
design. Hence, control group final values were estimated to 12 months using last observation carried 19 
forward.  Scenario three is from the perspective of the government health sector with a six-month 20 
timeframe and includes health care costs.  21 
As the cost-effectiveness analyses have a short time horizon, costs and health outcomes were not 22 
discounted. 23 
Per-protocol and intention to treat approaches were completed for all analyses. Per-protocol 24 
analyses included complete cases only, whereas intention to treat analyses incorporated multiple 25 
imputation (m=10) using the “mice” package (Buuren & Groothuis-Oudshoorn, 2011) in the R 26 
9 
 
programming language to replace missing data. Imputation models included age, sex, health care 1 
resource utilisation, Geriatric Anxiety Index (Pachana et al., 2007) scores and Geriatric Depression 2 
Scale (Kurlowicz, 1999) scores. Uncertainty in estimates were quantified using 10,000 bootstrap 3 
samples (with replacement) for per-protocol-analyses and 1,000 bootstrap samples (with 4 
replacement) for each of the 10 imputed data sets for intention to treat analyses. Both mean and 5 
median-based ICERs (Bang & Zhao, 2012) were calculated with scatterplots on the cost-effectiveness 6 
plane used to illustrate joint distribution of cost and effectiveness outcomes. 7 
  8 
RESULTS 9 
A total of 245 older adults met the eligibility criteria, were enrolled into the study and were 10 
randomized into the immediate intervention (n=86) and wait-list control (n=159) groups. Of these, 11 
215 participants (intervention = 86; control = 129) commenced and 30 participants (control = 30) did 12 
not commence the exercise program. Of those that commenced the exercise program, 168 13 
participants (intervention = 67; control = 101) finished the program and 47 participants (intervention 14 
19; control = 28) did not finish the program. Participants who completed the exercise intervention 15 
attended, on average, 90% of the 48 sessions. Of the 168 participants who completed the exercise 16 
intervention, 119 continued to attend exercise sessions at the center at least once a week during the 17 
follow up period. Follow up data were available for 129 participants. Further analysis is provided in 18 
the online Appendix 2. 19 
The average age at baseline assessment was 78.7 ± 6.4 years and 79% of the participants were 20 
female. A total of 41% of participants used aids to mobility (a walking stick or wheelie walker). 21 
Participants were predominately older females with multiple morbidities. There were no significant 22 
differences between the group who began exercise immediately and the wait-list control group in 23 
age (p=.65), mobility aid use (p=1.0), number of medications (p=.95), number of morbidities (p=.97) 24 
or EQ-5D-3L score (p=.28). There was a significant difference in SPPB score between the two groups 25 
(p=.05). Diaries were completed by 127 out of the 168 participants who completed the exercise 26 
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intervention and these diary entries were used to inform the health care usage costs. Reasons for 1 
non-completion of diaries were vision impairment, low literacy and the burden of completing a daily 2 
diary over an extended period of time (48 weeks for those randomized to immediate exercise and 72 3 
weeks for those randomized to be wait-list controls). There were no significant differences in 4 
baseline measures of age, medications, morbidities, SPPB score and EQ-5D-3L score between those 5 
who did and did not complete diaries. 6 
 7 
Outcomes  8 
Health-related quality of life and physical function for the per-protocol and intention to treat 9 
analyses are presented in Table 1. There is a significant difference in health-related quality of life 10 
utilities scores (derived from the EQ-5D-3L) between groups over the 24-week period; the control 11 
group declined slightly (-0.02 in the per-protocol and intention to treat analyses) from baseline to 12 
pre-exercise compared to the combined intervention group which improved by 0.06 and 0.05 (per-13 
protocol and intention to treat analyses, respectively) from pre- to post-exercise. Participants in the 14 
combined intervention group continued to significantly improve post completion of the program 15 
with an average of 0.10 utility score improvement at follow up compared to baseline. 16 
Physical function, as demonstrated by SPPB scores, did not vary in the control group from baseline 17 
to pre-exercise (intention to treat analysis) whereas the combined group improved significantly from 18 
pre- to post-exercise by 1.5 and 1.2 points (per protocol and intention to treat analyses, 19 
respectively). 20 
 21 
<insert Table 1 about here> 22 
 23 
Costs 24 
Table 2 shows the resource and health care events and costs used in the analyses. High cost items 25 
include hospitalisation ($2,024 per overnight hospitalisation) and transport to and from the exercise 26 
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clinic ($1920 per person requiring transport). The delivery of the Muscling Up Against Disability 1 
program comprises a small proportion of the overall costs ($303 per person). 2 
 3 
<insert Table 2 about here> 4 
 5 
Cost-effectiveness analysis 6 
Incremental cost-effectiveness ratios of the Muscling Up Against Disability program compared with 7 
usual care (plus healthy living seminars) are shown in Table 3. Using a willingness to pay for a QALY 8 
in Australia of $64,000 (Shiroiwa et al., 2010), the base case (strict within trial of six months) is 9 
unlikely to be considered cost-effective. Muscling Up Against Disability is highly likely to be cost-10 
effective when benefits are extrapolated over 12 months (Scenario 2). Cost-effectiveness 11 
acceptability curves are presented in Figures 1(a) and 1(b). 12 
Scenario three reduces the base case ICER as health care costs were lower in the intervention group. 13 
This improved the ICER to under the $64,000 threshold with a 65% likelihood of being cost-effective 14 
at this willingness to pay (Table 3). 15 
 16 
<insert Table 3 about here> 17 
<insert Figure 1 about here> 18 
 19 
The model is highly sensitive to the number of participants requesting transport. In the base case, 20 
approximately half the cohort requested transport. The mean trip distance calculated for these 21 
participants was 5 kilometres each way (range 1-14 km; median 5 km) and the average time per trip 22 
(including mobility assistance into and out of the vehicle at each end) was estimated at 30 minutes. 23 
Without these transport costs, the ICER over six months reduced to under $20,000. If all participants 24 
requested transport the ICER is greater than $110,000 (Table 4). 25 
 26 
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<insert Table 4 about here> 1 
 2 
 3 
DISCUSSION 4 
This study reports on the cost-effectiveness at six and 12 months of the Muscling Up Against 5 
Disability program. The findings suggest that the program offers value for money for health service 6 
providers compared with usual care plus healthy living seminars as the ICER is below the commonly 7 
accepted WTP threshold in Australian of $64,000 per QALY (Shiroiwa et al., 2010) when the benefits 8 
are continued for a 12-month period. The benefits are not as clear when measured only over the six 9 
month intervention period. The ICER is primarily driven by transport costs in this study. From a 10 
government perspective, the intervention can be considered to be good value for money across its 11 
six month delivery period. 12 
Participants improved both on quality of life (EQ-5D-3L increase of 0.10) and physical function (SPPB 13 
increase of 1.5). These total improvements over 12 months were more than the minimally clinically 14 
significant differences of 0.074 for EQ-5D-3L (Walters & Brazier, 2005) and 0.80 for the SPPB (Kwon 15 
et al., 2009). Continuing improvements from post-intervention to follow up can be ascribed to the 16 
large percentage of participants who continued to exercise at the center. These improvements came 17 
at a program cost of $321 per participant. Simply put, these were large and meaningful changes over 18 
12 months at a modest cost. Program cost for the Muscling Up Against Disability program ($321, 19 
excluding transport costs) compares very favorably with both the LIFE study, with an average cost of 20 
US$635 (A$864) for six months (Groessl et al., 2016), and Project ACTIVE at US$1141 (A$1552) for six 21 
months of delivery (Sevick et al., 2000). 22 
For those requesting transport to and from the study site the additional cost was $1,920 per 23 
participant. Transport was considered integral to the success of the program. Participants had a high 24 
incidence of mobility aid usage, high morbidity count and poor baseline performance on the SPPB 25 
which was suggestive of frailty (Guralnik et al., 1994). Without the provision of transport the 26 
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observed effects may have been reduced as many participants could not have accessed the site 1 
independently and participation rates may have been impacted. Although the transport costs were 2 
high, the large and meaningful changes reported here would be far less if participants had had the 3 
functional capability to transport themselves to the venue. 4 
 5 
Limitations 6 
This economic evaluation has several limitations that need to be considered before generalizing 7 
these findings. This study was limited to one site in an urban area in Australia. Some of the costs 8 
used in the analysis are specific to this site. For example, the cost-effectiveness was highly sensitive 9 
to the transport costs used in this analysis. These costs were high due to the nature of the provider 10 
fleet service and are unlikely to be consistent with other settings. High costs were attributable to 11 
wage expenses for a predominantly paid driver fleet and extra time allocated to each trip to provide 12 
mobility assistance at the participant’s home and at the exercise clinic. Costs for fleet administration 13 
and coordination were included in the overall transport costs. The cost-effectiveness would be 14 
considerably better than demonstrated in these findings if less expensive transport options were 15 
used. In addition, diary data were not available for all participants who completed the intervention. 16 
 17 
Summary 18 
Muscling Up Against Disability, a progressive resistance plus balance training program, has been 19 
shown to be both efficacious and cost-effective. It represents a good value proposition for 20 
organizations wanting to implement an exercise programs to assist older adults experiencing 21 
functional decline requiring in-home care services. Provision of transport is worthy of consideration 22 
for its positive impact on participation and organizations may well be able to secure more 23 
economical options than the fleet services used in this study. In an effort to improve the cost-24 
effectiveness of future interventions, researchers would do well to investigate alternate scenarios 25 
that overcome the expense of providing transport. This could include implementing programs such 26 
14 
 
as Muscling Up Against Disability closer to the target population, in community centers and 1 
retirement living complexes.  2 
15 
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Appendix 1. Consort flow diagram 
 
Appendix 1: Additional analyses 
 
Supplementary Table A: Baseline variables and one-way ANOVA results comparing completion categories. 
 
Measure 
Cohort 
(245) 
DNS 
(30) 
DNF 
(47) 
FIN 
(168) 
ANOVA results LSD results 
 M (SD) M (SD) M (SD) M (SD) F value p value  
Age (yrs) 78.7 (6.4) 80.4 (7.1) 79.0 (6.5) 78.3 (6.3) 1.4 .25  
Medications (n) 5.2 (3.2) 5.0 (3.8) 5.7 (3.4) 5.1 (3.1) 0.6 .54  
Morbidities (n) 5.0 (2.8) 4.6 (3.4) 6.1 (2.8) 4.8 (2.6) 4.3 .01 DNF > DNS*, FIN** 
SPPB 8.0 (2.8) 6.2   (2.5) 7.0 (3.0) 8.6 (2.5) 15.6 .00 FIN > DNS*, FIN** 
EQ-5D 0.78 (0.15) 0.75 (0.14) 0.74 (0.18) 0.79 (0.14) 2.4 .10  
Note. DNS – Did not start; DNF – Did not finish; FIN – Finished; SPPB – Short Physical performance Battery; EQ-5D – EuorQoL 5D 
Results from least significant difference (LSD) calculations - *p < .05, **p < .01 
 
Figure 1. Cost-effectiveness acceptability curves for (a) Scenario 1A, and (b) Scenario 2A 
 
Table 1. Health-related quality of life (EQ-5D-3L) and physical function (SPPB) for per-protocol and 
intention to treat analyses. 
Analysis  Baseline 24-weeks 48-weeks 
EQ-5D-3L score    
Control (PP) 0.73±0.16 (159) 0.71±0.19 (128)  
Control (ITT) 0.73±0.16 (159) 0.71±0.19 (159)  
Intervention (PP) 0.73±0.19 (214) 0.79±0.19† (167) 0.83±0.15† (129) 
Intervention (ITT) 0.72±0.19 (245) 0.77±0.20† (245) 0.82±0.16†‡ (245) 
SPPB score    
Control (PP) 7.7±2.8 (159) 8.0±3.2 (129) 
Control (ITT) 7.7±2.8 (159) 7.7±3.2 (159) 
Intervention (PP) 8.2 ±3.0 (215) 9.7 ±2.8† (168) 10.0 ±2.3† (129) 
Intervention (ITT) 8.0±3.0 (245) 9.2±3.0† (245) 9.5±2.6† (245) 
Note. Values are expressed mean±SD (N); Baseline refers to the control baseline; Pre-exercise refers to 
the control pre-exercise and intervention baseline; ITT = intention to treat analysis; MUAD = Muscling 
Up Against Disability; PP = per-protocol analysis; SPPB = short physical performance battery 
† Significantly different from baseline (p<0.05) 
‡ Significantly different from 24-weeks (p<0.05) 
 
Table 2. Costs of resource items and health care use 
Item Intervention Control Cost Source Included in 
Resources (24-weeks): N N / person   
Exercise intervention 86 159 $245 Trail All 
Healthy living 
seminars 
0 159 $19.12 Trail All 
Overheads* 86 159 $14.69 Trail All 
Equipment** 86 159 $61.57 Trail All 
Transport 50 73 $1,920 Trail All 
Health care use N(events) N(events) / event   
ED presentation 20 (33) 32 (68) $531 IHPA11 Scenario 3 
ED presentation and 
admission 
12 (30) 30 (64) $955 IHPA11 Scenario 3 
Overnight hospital 
stay 
19 (48) 42 (180) $,2024 IHPA11 Scenario 3 
General practice visit 52 (704) 75 (1451) $78 AMA 12 Scenario 3 
Other specialist visit 49 (869) 71 (1763) $166 AMA 12 Scenario 3 
Note. Resource costs are mean costs per person. Health care items are number of participants reporting 
events (total number of events reported); AMA = Australian medical association; ED = emergency 
department; IHPA = independent hospital pricing authority; MUAD = Muscling Up Against Disability 
program 
*Overheads included facility costs (power, cleaning) and administration personnel 
** Equipment costs were lease expenses for the HUR pneumatic exercise equipment 
Table 3. Results of the cost-effectiveness scenarios 
Analysis No. Intervention Control Cost Effect ICER Probability cost-
effective* 
Scenario 1: Service provider perspective within trial (6 months) 
Cost-utility analysis        
Intention to treat 1A 245 159 $1,082 (1040-
1,125) 
0.015 (0.012 – 
0.019) 
$70,540 (57,861 – 
89,410) 
0.38 
Per-protocol 1B 167 128 $1,141 (1061 -
1220) 
0.017 (0.013-
0.021) 
$68,714 (57509 – 
84766) 
0.40 
Cost-effectiveness 
analysis 
       
Intention to treat 1C 245 159 $1,082 (1040-
1,125) 
1.16 (0.97 – 1.35) $934 (795 – 1121) N/A 
Per-protocol 1D 167 128 $1,141 (1061 -
1220) 
1.19 (1.02 – 1.37) $976 (843 – 1148) N/A 
Scenario 2: Service provider perspective within trial with follow up (12 months) 
Cost-utility analysis        
Intention to treat 2A 245 159 $2,166 (2,079-
2,253) 
0.057 (0.048 – 
0.066) 
$37,816 (32,415 – 
45,307) 
0.95 
Per-protocol 2B 129 128 $2,247 (2,131-
2,360) 
0.066 (0.057 – 
0.075) 
$34,015 (29,589 – 
39,558) 
0.99 
Cost-effectiveness 
analysis 
       
Intention to treat 2C 245 159 $2,166 (2,079-
2,253) 
1.38 (1.18 – 1.56) $1,574 (1,375– 1,841) N/A 
Per-protocol 2D 129 128 $2,247 (2,131-
2,360) 
1.35 (1.17 – 1.52) $1,668 (1,459 – 1,920) N/A 
Scenario 3: Government health sector perspective with health care costs (6 months)  
Cost-utility analysis        
Per-protocol 3A 124 74 $859 (-419-
1,307) 
0.018 (0.015 – 
0.022) 
$47,747 (22,645 – 
77,236) 
0.65 
Cost-effectiveness 
analysis 
       
Per-protocol 3B 124 74 $859 (-419-
1,307) 
1.12 (0.92 – 1.32) $771 (371 – 1,224) N/A 
Note. *Probability based of a willingness to pay estimated for Australia of $64,000 22; Cost-utility analysis outcome was quality adjusted life years 
(QALYs); Cost-effectiveness analysis outcome was change in short physical performance battery (SPPB) score; CI = confidence interval; ICER = 
incremental cost-effectiveness ratio; N/A = not applicable 
Table 4: Sensitivity analysis 
No. Analysis (ITT) Intervention Control Cost Effect 
(95% CI) 
ICER Probability cost-
effective* 
1AS1 No Travel 245 159 $303† 0.015 (0.012 – 
0.019) 
$19,780 (16,281 – 
24,749) 
0.99 
1AS2 100% Travel 245 159 $1,823†   0.015 (0.012 – 
0.019) 
$119,043 (97,988 – 
148,949) 
0.01 
Note. *Probability based of a willingness to pay estimated for Australia of $64,000 22; ITT=intention to treat 
† does not include cost of healthy living seminars (usual care control intervention) 
